AI Technology Dr Noon Predicts Heart Disease Risk Using Retina Scans

A groundbreaking artificial intelligence technology named Dr Noon is set to revolutionize cardiovascular health screening in Indonesia. This innovative system analyzes retinal images to predict the risk of Atherosclerotic Cardiovascular Disease (ASCVD), offering a new, non-invasive approach to identifying potential heart problems.

Developed in South Korea, Dr Noon utilizes advanced AI algorithms to examine the intricate details within retina photographs. By studying these images, the technology can flag individuals at risk of ASCVD, a condition characterized by the buildup of plaque in arteries. This capability allows for early intervention, potentially preventing serious cardiac events.

The system's utility extends beyond cardiovascular risk assessment. Dr Noon can also assist in detecting a range of other eye health disorders. This dual functionality makes it a powerful tool for comprehensive health screening, identifying issues that might otherwise go unnoticed during routine check-ups.

The introduction of Dr Noon in Indonesia was highlighted during a symposium in Jakarta titled "Novel Methods to Predict ASCVD Risk." The event featured insights from Dr. Sahil Thakur, a clinician scientist and ophthalmologist from Singapore, who discussed the burgeoning field of oculomics – the study of eye-related data for health insights. The symposium underscored the growing importance of leveraging technology like AI for proactive healthcare solutions.